{
    "Trade/Device Name(s)": [
        "Biolis 24i",
        "MGC 240",
        "Prestige 24i"
    ],
    "Submitter Information": "Tokyo Boeki Medisys Inc.",
    "510(k) Number": "K103531",
    "Predicate Device Reference 510(k) Number(s)": [
        "K904219",
        "K802810",
        "K070207"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JJE"
    ],
    "Summary Letter Date": "November 4, 2011",
    "Summary Letter Received Date": "November 8, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Biolis 24i",
        "MGC 240",
        "Prestige 24i"
    ],
    "Method(s)/Technology(ies)": [
        "Photometry",
        "Indirect potentiometry (for ISE module)",
        "Photometric endpoint using glucose hexokinase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Biolis 24i Clinical Chemistry Analyzer measuring glucose and electrolytes in serum using photometry and optional ISE module.",
    "Indications for Use Summary": "Discrete photometric clinical chemistry analyzer automating manual procedures for measuring analytes including glucose in serum; glucose measurements aid diagnosis and treatment of carbohydrate metabolism disorders.",
    "fda_folder": "Clinical Chemistry"
}